SCHEMBL20324038

SCHEMBL20324038

CCCC1CC(S)C(C)C1C

nearest known ligand 0.36

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ NOS1 P29475 2/20 0.36
▸ NOS2 P35228 2/20 0.36
▸ CA1 P00915 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ CA4 P22748 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20334488 0.76 — —
SCHEMBL24862909 0.71 NOS1 (0.41) NOS1NOS2CA1CA2CA4
SCHEMBL24520374 0.68 — —
SCHEMBL25101526 0.68 NOS1 (0.38) NOS1NOS2CA1CA2CA4
SCHEMBL910154 0.68 — —
SCHEMBL18828488 0.68 — —
SCHEMBL16411466 0.67 — —
SCHEMBL24146631 0.66 NOS1 (0.32) NOS1NOS2
Hydrogen Sulfide SCHEMBL5678855 0.66 — —
SCHEMBL20936643 0.65 CA1 (0.35) CA1CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018118627-A1 EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY SAREPTA THERAPEUTICS, INC. (US) 2018-06-28 — — WO disclosed
WO-2018118662-A1 EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY SAREPTA THERAPEUTICS, INC. (US) 2018-06-28 — — WO disclosed
Send feedback